Sign in
4

Changes in Ownership

AMGEN INC Filed Acc 0001127602-24-004620

EVP, R&D, & Chief Sci. Officer acquired 22,393 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bradner James E. EVP, R&D, & Chief Sci. Officer 2024-02-09 Grant or award +8,587 8,587 D
Bradner James E. EVP, R&D, & Chief Sci. Officer 2024-02-09 Grant or award +13,806 22,393 D
Loading xslF345X05/form4.xml…